| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |